Literature DB >> 21921140

Macrophages promote cyst growth in polycystic kidney disease.

Anil Karihaloo1, Farrukh Koraishy, Sarah C Huen, Yashang Lee, David Merrick, Michael J Caplan, Stefan Somlo, Lloyd G Cantley.   

Abstract

Polycystic kidney disease (PKD) exhibits an inflammatory component, but the contribution of inflammation to cyst progression is unknown. Macrophages promote the proliferation of tubular cells following ischemic injury, suggesting that they may have a role in cystogenesis. Furthermore, cultured Pkd1-deficient cells express the macrophage chemoattractants Mcp1 and Cxcl16 and stimulate macrophage migration. Here, in orthologous models of both PKD1 and PKD2, abnormally large numbers of alternatively activated macrophages surrounded the cysts. To determine whether pericystic macrophages contribute to the proliferation of cyst-lining cells, we depleted phagocytic cells from Pkd1(fl/fl);Pkhd1-Cre mice by treating with liposomal clodronate from postnatal day 10 until day 24. Compared with vehicle-treated controls, macrophage-depleted mice had a significantly lower cystic index, reduced proliferation of cyst-lining cells, better-preserved renal parenchyma, and improved renal function. In conclusion, these data suggest that macrophages home to cystic areas and contribute to cyst growth. Interruption of these homing and proliferative signals could have therapeutic potential for PKD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921140      PMCID: PMC3187181          DOI: 10.1681/ASN.2011010084

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  23 in total

Review 1.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

2.  Macrophages contribute to the initiation of ischaemic acute renal failure in rats.

Authors:  Sang-Kyung Jo; Su-Ah Sung; Won-Yong Cho; Kang-Jee Go; Hyoung-Kyu Kim
Journal:  Nephrol Dial Transplant       Date:  2006-01-12       Impact factor: 5.992

3.  The intracellular domain of CD44 promotes the fusion of macrophages.

Authors:  Weiguo Cui; Juan Zhang Ke; Qing Zhang; Hua-Zhu Ke; Cécile Chalouni; Agnès Vignery
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

4.  Overexpression of innate immune response genes in a model of recessive polycystic kidney disease.

Authors:  M Mrug; J Zhou; Y Woo; X Cui; A J Szalai; J Novak; G A Churchill; L M Guay-Woodford
Journal:  Kidney Int       Date:  2007-10-24       Impact factor: 10.612

Review 5.  Advances in the pathogenesis and treatment of polycystic kidney disease.

Authors:  Vishal Patel; Renuka Chowdhury; Peter Igarashi
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-03       Impact factor: 2.894

Review 6.  Polycystic kidney disease.

Authors:  Peter C Harris; Vicente E Torres
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

7.  Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo.

Authors:  Feng Wei; Anil Karihaloo; Vikas P Sukhatme; Zhiheng Yu; Arnaud Marlier; Pankaj Seth; Sekiya Shibazaki; Tong Wang; Stefan Somlo; Lloyd G Cantley
Journal:  Kidney Int       Date:  2008-08-13       Impact factor: 10.612

8.  A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li; Brenda S Magenheimer; Sheng Xia; Teri Johnson; Darren P Wallace; James P Calvet; Rong Li
Journal:  Nat Med       Date:  2008-06-15       Impact factor: 53.440

9.  Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.

Authors:  Vishal Patel; Ling Li; Patricia Cobo-Stark; Xinli Shao; Stefan Somlo; Fangming Lin; Peter Igarashi
Journal:  Hum Mol Genet       Date:  2008-02-09       Impact factor: 6.150

10.  Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.

Authors:  Sekiya Shibazaki; Zhiheng Yu; Saori Nishio; Xin Tian; R Brent Thomson; Michihiro Mitobe; Angeliki Louvi; Heino Velazquez; Shuta Ishibe; Lloyd G Cantley; Peter Igarashi; Stefan Somlo
Journal:  Hum Mol Genet       Date:  2008-02-07       Impact factor: 6.150

View more
  88 in total

1.  Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.

Authors:  Xia Zhou; Lucy X Fan; Dorien J M Peters; Marie Trudel; James E Bradner; Xiaogang Li
Journal:  Hum Mol Genet       Date:  2015-04-15       Impact factor: 6.150

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

Review 3.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 4.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

5.  Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Authors:  Kelli M Sas; Hong Yin; Wayne R Fitzgibbon; Catalin F Baicu; Michael R Zile; Stacy L Steele; May Amria; Takamitsu Saigusa; Jason Funk; Marlene A Bunni; Gene P Siegal; Brian J Siroky; John J Bissler; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-22

Review 6.  Rationale for early treatment of polycystic kidney disease.

Authors:  Jared J Grantham
Journal:  Pediatr Nephrol       Date:  2014-07-15       Impact factor: 3.714

7.  Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease.

Authors:  John R Montford; Colin Bauer; Evgenia Dobrinskikh; Katharina Hopp; Moshe Levi; Mary Weiser-Evans; Raphael Nemenoff; Seth B Furgeson
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-16

Review 8.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

9.  Primary cilia disruption differentially affects the infiltrating and resident macrophage compartment in the liver.

Authors:  Kurt A Zimmerman; Cheng Jack Song; Nancy Gonzalez-Mize; Zhang Li; Bradley K Yoder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-15       Impact factor: 4.052

10.  PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.

Authors:  Ronak Lakhia; Matanel Yheskel; Andrea Flaten; Ezekiel B Quittner-Strom; William L Holland; Vishal Patel
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.